4.7 Review

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

期刊

LEUKEMIA
卷 -, 期 -, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41375-023-02048

关键词

-

向作者/读者索取更多资源

The article discusses laboratory management methods for patients with CML, including accurate diagnosis, assessment of prognostic markers, sequential assessment of residual disease levels, and investigation of reasons for resistance, relapse, or progression. The recommendations focus on current best practices and highlight the strengths and pitfalls of commonly used laboratory tests.
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据